Search Results - "Horsmans, Y"

Oligofructose promotes satiety in healthy human: a pilot study by Cani, P.D, Joly, E, Horsmans, Y, Delzenne, N.M

“…Objective: The administration of a fermentable dietary fibre (oligofructose) in rats increases satietogenic gut peptides and lowered spontaneous energy intake…”
Get full text

Increased non-shivering thermogenesis had preventive but no therapeutic effects on non-alcoholic steatohepatitis by Poekes, L, Horsmans, Y, Farrell, G, Leclercq, I.A

Get full text

Impact of liver inflammation on whole body insulin resistance : a case report on primary biliary cholangitis by Clarembeau, F, Komuta, M, Horsmans, Y, Lanthier, N

“…Chronic liver diseases such as hepatitis C or non-alcoholic fatty liver disease could be associated with insulin resistance, even in the absence of cirrhosis…”
Get more information

Treatment of chronic hepatitis C in elderly patients by Horsmans, Y

“…The issue of age in cases of chronic hepatitis C (HCV) in the West is a major problem; the average age of patients with HCV is increasing and its prevalence…”
Get more information

Interferon-induced depression in chronic hepatitis C by HORSMANS, Y

“…Since the success rate of the antiviral treatment of chronic hepatitis C (HCV) is increasing, the knowledge of side effects due to this therapy must also…”
Get full text

Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents by Hamoir, C, Horsmans, Y, Stärkel, P, Dahlqvist, G, Negrin Dastis, S, Lanthier, N

“…Cirrhosis associated to chronic hepatitis C virus (HCV) is one of the leading cause of hepatocellular carcinoma (HCC). The goal of our study was to evaluate…”
Get more information

Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo by Fiasse, R, Horsmans, Y, Mbusa, R.K, Kabamba, B.M, Shindano, T.A

“…Background. The World Health Organization recommends the integration of vaccination against hepatitis B virus (HBV) into the national immunisation programmes…”
Get full text

Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling by Delire, B, Lebrun, V, Selvais, C, Henriet, P, Bertrand, A, Horsmans, Y, Leclecrq, I

Get full text

Acute liver graft cellular rejection after interferon-free antiviral treatment for HCV infection. Is there a risk? A warning about three cases by Dahlqvist, G, Horsmans, Y, Komuta, M, Coubeau, L

“…All patients transplanted for hepatitis C (HCV)- related cirrhosis will experience a recurrence of the viral disease on the liver graft with an accelerated…”
Get more information

Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms by Charette, N, De Saeger, C, Horsmans, Y, Leclercq, I, Stärkel, P

“…Ras activation is a frequent event in human hepatocarcinoma that may contribute to resistance towards apoptosis. Salirasib is a ras and mTOR inhibitor that…”
Get full text

Mucin-producing hepatic cystic neoplasms: an uncommon but challenging disease often misdiagnosed and mismanaged by Frezin, J., Komuta, M., Zech, F., Annet, L., Horsmans, Y., Gigot, J. F., Jouret-Mourin, A., Hubert, C.

“…Background: Mucin-producing hepatic cystic neoplasms (MHCN) are uncommon and potentially malignant. Methods: Nine MHCN were encountered in our centre for over…”
Get full text

Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis by Muyldermans, G, Bielen, R, Botterman, R, Bourgeois, S, Colle, I, Deressa, B, Devolder, G, Horsmans, Y, Hutse, V, Lanthier, N, Lasser, L, Platteau, S, Robaeys, G, Suin, V, Verhelst, X, Van Vlierberghe, H, Van Baelen, L

“…Although multiple HCV prevalence studies were recently performed in the general population from Belgium, they suffer from a lack of geographical…”
Get more information

The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver by Borbath, I, Leclercq, I, Moulin, P, Sempoux, C, Horsmans, Y

“…Abstract Hepatocellular carcinoma (HCC) is increasing worldwide and is the fifth main cause of cancer-related death. HCC develops on a preneoplastic organ, the…”
Get full text

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of pilot study by Daubioul, C.A, Horsmans, Y, Lambert, P, Danse, E, Delzenne, N.M

“…Objective: In experimental animals, recent results suggest that the addition of inulin-type fructans such as oligofructose (OFS) in the diet decreases…”
Get full text

Patients above 65 years of age achieved the same SVR12 as younger patients despite increased comorbidities: findings from a large real-world, multi-country, observational cohort of 12-week ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin by Flisiak, R, Maieron, A, Kraus, M, Leroy, V, Horsmans, Y, Hunyady, B, Norris, S, Bondin, M, Latarska-Smuga, D, dos Santos, A.P, Martinez-Tristani, M, Conway, B

Get full text

Hepatic Perfusion Parameters in Chronic Liver Disease: Dynamic CT Measurements Correlated with Disease Severity by Van Beers, Bernard E, Leconte, Isabelle, Materne, Roland, Smith, Anne M, Jamart, Jacques, Horsmans, Yves

“…The aim of our study was to determine if hepatic perfusion parameters measured with CT change in relation to disease severity in patients with chronic liver…”
Get full text

P330 ACTIVATION OF INTERFERON AND NF-κB PATHWAYS IN EARLY HUMAN ALCOHOLIC LIVER DISEASE DEVELOPMENT by Stärkel, P, Lanthier, N, De Saeger, C, Sempoux, C, Leclercq, I.A, Horsmans, Y

Get full text

EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis by Forns, X, Lee, S, Valdes, J, Lens, S, Ghalib, R, Aguilar, H, Felizarta, F, Hassanein, T, Hinrichsen, H, Rincon, D, Morillas, R, Zeuzem, S, Horsmans, Y, Nelson, D, Yu, Y, Pilot-Matias, T, Lin, C.-W, Mensa, F

Get full text

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats by Leclercq, I A, Sempoux, C, Stärkel, P, Horsmans, Y

“…Aim: Peroxisome proliferator activated receptor γ (PPARγ) agonists have been shown to prevent hepatic fibrosis in rodents. We evaluated the therapeutic…”
Get full text

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis by Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S

Get full text